Kineret
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5929 Queenslodge 108, Houston, Texas, 77...Website
www.kineretrx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Kineret
Sobi, Inc. specializes in the development and commercialization of KINERET (anakinra), an interleukin-1 receptor antagonist approved for treating moderate to severe rheumatoid arthritis (RA), neonatal-onset multisystem inflammatory disease (NOMID), and deficiency of interleukin-1 receptor antagonist (DIRA). The company targets healthcare professionals and patients who have not responded to other treatments for these conditions. KINERET is unique in its mechanism of action, specifically blocking IL-1, which is a key driver of inflammation in these diseases. Sobi, Inc. also offers support programs to assist patients in managing their treatment and addressing any concerns related to KINERET.Explore more
Popular SearchesKineretKineret Engineering IncKineret IncKineret LLClicensed by Swedish Orphan Biovitrum ABSIC Code 28,283NAICS Code 32,325Show moreKineret Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kineret your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Kineret had a recent Job posting/layoffs
Earning: See what the market has to say on Kineret recently announced quarterly report
Product Launch: Get notified when Kineret launches new products
Congratulate Masked Content for being promoted to Masked Content at Kineret
Funding: Get notified immidiatlly once Kineret has new funding data
Check if Kineret has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Kineret, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Kineret is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Kineret
Compare insights from companies similar to Kineret, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kineret is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kineret is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kineret.
Kineret Tech Stack
A closer look at the technologies used by Kineret
See more technologies
Kineret News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kineret
Sign Up For FreeTo access detailed company insights
Sobi, Inc. specializes in the development and commercialization of KINERET (anakinra), an interleukin-1 receptor antagonist approved for treating moderate to severe rheumatoid arthritis (RA), neonatal-onset multisystem inflammatory disease (NOMID), and deficiency of interleukin-1 receptor antagonist (DIRA). The company targets healthcare profession... Read More
